Value of the bethesda system for reporting (tbsrtc) thyroid cytopathology

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     2    0

Abstract

Background: Objectives: to determine the stratification and risk of malignancy of Bethesda system’s subgroups for reporting thyroid cytopathology, in addition, compare with Thyroid Imaging Reporting and Data System [TI-RADS] in diagnosing benign and malignant thyroid nodules.

Method: - Retrospective cross - sectional descriptive study. Collect data of 202 thyroid nodules from 193 patients admitted at the Hospital of in Hue University of Medicine and Pharmacy during the period 6/2018 to 5/2020.
Results: The average age uns 46.7 ± 14.5 years, women accounted for the majority (89.6%) and most patients had multiple thyroid nodules (79.2%). The proportion of Bethesda subgroups were : 0% (I); 38.6% (II); 0.5% (III); 30.2% (IV); 16.8% (V) and 13.9% (VI) with a malignant risk of 9% (II); 100% (III); 26.3% (IV); 76.4% (V) and 96.4% (VI). The percentage of TIRADS subgroups were: 6.9% (1); 11.4% (2); 30.2% (3); 34.2% (4) and 17.3% (5) with corresponding malignant risks were: 0% (1); 4.4% (2); 14.8% (3); 47.8% (4)
and 86.8% (5). Bethesda system has sensitivity, specificity, positive diagnostic value, negative diagnostic value of 69.7%; 92.8%; 85.5%; and 83.6% (with the cut off are groups V and VI). TIRADS system whose sensitivity, specificity, positive diagnostic value, negative diagnostic value were 86.8%; 67.5%; 61.6% and 89.4% respectively (cut off were groups of 4 and 5). The area under the curve (AUC) of Bethesda V, VI subgroups was 0.81 (p <0.001) and of TIRADS 4 and 5 subgroups was 0.25 (p <0.001).
Conclusion: The Bethesda system for reporting thyroid cytopathology was more valuable than Thyroid Imaging Reporting and Data System [TI-RADS] in diagnosing thyroid malignant nodules

https://doi.org/10.38103/jcmhch.2020.61.12

References

Cibas E. S. et al. (2017), “The 2017 Bethesda System for Reporting Thyroid Cytopathology”, J Am Soc Cytopathol. 6 (6), pp. 217 - 222.

Gao L. et al. (2019), “Comparison among TIRADS (ACR TI-RADS and KWAK- TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules”, Endocrine. 64 (1), pp. 90-96.

Tessler F. N. et al. (2017), “ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee”, J Am

Coll Radiol. 14 (5), pp. 587 - 595.

Châu Thị Hiền Trang (2015), “Nghiên cứu ứng dụng phân loại Tirads trong chẩn đoán tổn thương dạng nốt tuyến giáp trên siêu âm”, Điện quang Việt Nam. 21, pp. 17 - 22.

Nguyễn Xuân Hậu (2019), “Nghiên cứu giá trị sinh thiết hạch cửa trong bệnh ung thư tuyến giáp”, Luận án Tiến sĩ Y học, Trường Đại học Y

Hà Nội.

Modi L. et al. (2020), “Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytolog in the evaluation of thyroid nodules”, Cancer

Cytopathol.

Nguyễn Thị Chúc Biên (2015), “Áp dụng hệ thống phân loại Bethesda trong chẩn đoán tế bào học tuyến giáp”, Y học Thành phố Hồ Chí Minh. 19 (5), pp. 71 - 77.

Nguyễn Trúc Dung (2019), “Đặc điểm tế bào học và giải phẫu bệnh nhân giáp đã phẫu thuật”, Y học Thành phố Hồ Chí Minh. 23 (1), pp. 209 - 211.

Ozdemir D. et al. (2017), “Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification”, Cytopathology. 28 (5), pp. 400 - 406.

Sahli Z. T. et al. (2019), “The association between the ultrasonography TIRADS classification system and surgical pathology among indeterminate thyroid nodules”, Surgery. 165 (1), pp. 69 - 74.

Singaporewalla R. M. et al. (2017), “Clinicopathological Correlation of Thyroid Nodule Ultrasound and Cytology Using the TIRADS and

Bethesda Classifications”, World J Surg. 41 (7), pp. 1807 - 1811.

Tepeoglu M. et al. (2014), “A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal

categories: a series of 219 consecutive cases”, Cytopathology. 25 (1), pp. 39 - 44.

Published 26-01-2025
Fulltext
PDF (Tiếng Việt)     2    0
Language
Issue No. 61 (2020)
Section Original article
DOI 10.38103/jcmhch.2020.61.12
Keywords Phân loại Bethesda tế bào học tuyến giáp, phân loại siêu âm tuyến giáp TIRADS The Bethesda system, Thyroid Imaging Reporting and Data System [TI-RADS]

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Journal of Clinical Medicine Hue Central Hospital

Song, N. T. B., Thuan, D. C., Lan, L. T., Dong, T. N., Thao, L. T. T., & Sach, N. C. (2025). Value of the bethesda system for reporting (tbsrtc) thyroid cytopathology. Journal of Clinical Medicine Hue Central Hospital, (61), 83–87. https://doi.org/10.38103/jcmhch.2020.61.12